The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19 ...

With the latest COVID-19 surge, information on testing and vaccinations for those who are uninsured is becoming hard to find.

Robert F. Kennedy Jr. delivered a win to his anti-vaccine supporters on Thursday by reviving a task force meant to scrutinize ...

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...

Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.

Key Points GAAP revenue jumped 413% year over year to $11.8 million in Q2 2025, but fell far short of analyst estimates, with GAAP revenue of $11.8 million missing the consensus of $23.2 million by 49 ...

Invivyd ( ($IVVD) ) just unveiled an update. On August 14, 2025, Invivyd announced its alignment with the U.S. FDA on a rapid pathway to full ...

The FDA says they are considering ending authorization for healthy children between 6 months and 5 years old. Melania Trump ...

The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...

The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.